JFG
INBX icon

Jefferies Financial Group’s Inhibrx INBX Stock Holding History

Jefferies Financial Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.62M Buy
38,973
+30,072
+338% +$2.23M 0.02% 521
2025
Q4 		$703K Buy
+8,901
New +$606K ﹤0.01% 1233

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jefferies Financial Group's INBX Position: Q1 2026 in Review

Jefferies Financial Group increased its Inhibrx (INBX) stake by 338% in Q1 2026, buying an estimated $2.23M and bringing the position to 38,973 shares worth $2.62M. The position accounts for 0.02% of the portfolio, ranked #521.

Jefferies Financial Group first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Jefferies Financial Group held 38,973 shares of Inhibrx worth $2.62M as of Q1 2026.
  • Jefferies Financial Group bought 30,072 Inhibrx shares in Q1 2026, an estimated $2.23M.
  • Inhibrx made up 0.02% of Jefferies Financial Group's portfolio in Q1 2026, its #521 holding.
  • Jefferies Financial Group first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.